Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 6

Oral microbiota signatures in obesity with or without acanthosis nigricans in a Chinese cohort Open Access

Abstract

The oral microbiota is the second most complex microbial community in the human body. It has been suggested that poor oral health may be associated with an increased risk of obesity.

However, both previous observational and mechanistic studies on oral microbiota do not take into account the obesity-related acanthosis nigricans (AN), which is the most common dermatological manifestation in individuals with obesity.

This study aimed to investigate the altered composition, function and diagnostic value of the oral microbiota in obesity with or without acanthosis nigricans (AN).

We characterized the oral bacteria signature in a Chinese cohort (ChiCTR2300073353) of 99 patients with obesity and obesity-related AN (Ob_AN) and 50 healthy controls using 16S rRNA gene V3–V4 region sequencing.

The microbial richness (abundance-based coverage estimators and observed species indices) was significantly greater in the Ob_AN and obesity groups than in the control group; however, microbial diversity (Shannon index) did not differ significantly. Distinct separation in the microbial community amongst the three groups was observed. species, including , and , were associated with composition alterations and predicted functions (significant downregulation of ATP-binding cassette transporters) associated with microbial dysbiosis in the obesity and Ob_AN groups. Moreover, and genera assessments could indicate obesity and obesity-related AN risk.

The notable reduction of plenty of oral microbiota and high levels of spp. may play a critical role in obesity with AN. Oral microbiota may serve as biomarkers for diagnosing, preventing and even treating obesity-related AN.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): acanthosis nigricans , bacteria , obesity , oral microbiota and Prevotella
Funding
This study was supported by the:
  • National Natural Science Foundation of China (Award 82170887)
    • Principle Award Recipient: YanjunLiu
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.002020
2025-06-04
2025-06-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/6/jmm002020.html?itemId=/content/journal/jmm/10.1099/jmm.0.002020&mimeType=html&fmt=ahah

References

  1. Chen T, Chen X, Zhang S, Zhu J, Tang B et al. The Genome Sequence Archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinf 2021; 19:578–583 [View Article]
     [Google Scholar]
  2. Xue Y, Bao Y, Zhang Z, Zhao W, Xiao J et al. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2023. Nucleic Acids Res 2023; 51:D18–D28 [View Article]
     [Google Scholar]
  3. Pan X-F, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endo 2021; 9:373–392 [View Article]
     [Google Scholar]
  4. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019; 15:288–298 [View Article]
     [Google Scholar]
  5. de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut 2022; 71:1020–1032 [View Article] [PubMed]
     [Google Scholar]
  6. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021; 19:55–71 [View Article] [PubMed]
     [Google Scholar]
  7. Gao R, Zhu C, Li H, Yin M, Pan C et al. Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity. Obesity 2018; 26:351–361 [View Article] [PubMed]
     [Google Scholar]
  8. Manor O, Dai CL, Kornilov SA, Smith B, Price ND et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun 2020; 11:5206 [View Article] [PubMed]
     [Google Scholar]
  9. Hu J, Guo P, Mao R, Ren Z, Wen J et al. Gut microbiota signature of obese adults across different classifications. Diabetes Metab Syndr Obes 2022; 15:3933–3947 [View Article] [PubMed]
     [Google Scholar]
  10. Kunath BJ, De Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut microbiome axis in health and disease. Nat Rev Microbiol 2024; 22:791–805 [View Article] [PubMed]
     [Google Scholar]
  11. Tan X, Wang Y, Gong T. The interplay between oral microbiota, gut microbiota and systematic diseases. J Oral Microbiol 2023; 15:2213112 [View Article] [PubMed]
     [Google Scholar]
  12. Willis JR, Gabaldón T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms 2020; 8:308 [View Article]
     [Google Scholar]
  13. Hernandez BY, Zhu X, Goodman MT, Gatewood R, Mendiola P et al. Betel nut chewing, oral premalignant lesions, and the oral microbiome. PLoS One 2017; 12:e0172196 [View Article] [PubMed]
     [Google Scholar]
  14. Lu M, Xuan S, Wang Z. Oral microbiota: a new view of body health. Food Sci Hum Well 2019; 8:8–15 [View Article]
     [Google Scholar]
  15. Schamarek I, Anders L, Chakaroun RM, Kovacs P, Rohde-Zimmermann K. The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception. Nutr J 2023; 22:28 [View Article] [PubMed]
     [Google Scholar]
  16. Baker JL, Mark Welch JL, Kauffman KM, McLean JS, He X. The oral microbiome: diversity, biogeography and human health. Nat Rev Microbiol 2024; 22:89–104 [View Article] [PubMed]
     [Google Scholar]
  17. Gupta U, Dey P. The oral microbial odyssey influencing chronic metabolic disease. Arch Physiol Biochem 2024; 130:831–847 [View Article] [PubMed]
     [Google Scholar]
  18. Lê S, Laurencin-Dalicieux S, Minty M, Assoulant-Anduze J, Vinel A et al. Obesity is associated with the severity of periodontal inflammation due to a specific signature of subgingival microbiota. Int J Mol Sci 2023; 24:20 [View Article] [PubMed]
     [Google Scholar]
  19. Das A, Datta D, Kassir M, Wollina U, Galadari H et al. Acanthosis nigricans: a review. J Cosmet Dermatol 2020; 19:1857–1865 [View Article]
     [Google Scholar]
  20. Jones LH, Ficca M. Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes?. J Sch Nurs 2007; 23:247–251 [View Article] [PubMed]
     [Google Scholar]
  21. Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL. Acanthosis nigricans: an updated review. Curr Pediatr Rev 2022; 19:68–82 [View Article] [PubMed]
     [Google Scholar]
  22. Kutlubay Z, Engin B, Bairamov O, Tüzün Y. Acanthosis nigricans: a fold (intertriginous) dermatosis. Clin Dermatol 2015; 33:466–470 [View Article]
     [Google Scholar]
  23. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989; 87:269–272 [View Article] [PubMed]
     [Google Scholar]
  24. Patel NU, Roach C, Alinia H, Huang WW, Feldman SR. Current treatment options for acanthosis nigricans. Clin Cosmet Inv Derm 2018; 11:407–413 [View Article] [PubMed]
     [Google Scholar]
  25. Romo A, Benavides S. Treatment options in insulin resistance obesity-related acanthosis nigricans. Ann Pharmacother 2008; 42:1090–1094 [View Article] [PubMed]
     [Google Scholar]
  26. Hong X, Qin P, Yin J, Shi Y, Xuan Y et al. Clinical manifestations of polycystic ovary syndrome and associations with the vaginal microbiome: a cross-sectional based exploratory study. Front Endocrinol 2021; 12:662725 [View Article]
     [Google Scholar]
  27. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019; 37:852–857 [View Article]
     [Google Scholar]
  28. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 2016; 13:581–583 [View Article] [PubMed]
     [Google Scholar]
  29. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 2002; 30:3059–3066 [View Article] [PubMed]
     [Google Scholar]
  30. Price MN, Dehal PS, Arkin AP. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One 2010; 5:e9490 [View Article] [PubMed]
     [Google Scholar]
  31. Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome 2018; 6:90 [View Article]
     [Google Scholar]
  32. Kaehler BD, Bokulich NA, McDonald D, Knight R, Caporaso JG et al. Species abundance information improves sequence taxonomy classification accuracy. Nat Commun 2019; 10:4643 [View Article] [PubMed]
     [Google Scholar]
  33. Chao A. Nonparametric estimation of the number of classes in a population. Scand J Stat 1984; 11:265–270
     [Google Scholar]
  34. Shannon CE. In The Mathematical Theory of Communication vol 14 MD computing: computers in medical practice; 1963 pp 306–317
     [Google Scholar]
  35. Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol 2020; 38:685–688 [View Article] [PubMed]
     [Google Scholar]
  36. Lyu F, Han F, Ge C, Mao W, Chen L et al. OmicStudio: a composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication. iMeta 2023; 2:e85 [View Article] [PubMed]
     [Google Scholar]
  37. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016; 387:1377–1396 [View Article]
     [Google Scholar]
  38. Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017; 390:2627–2642 [View Article]
     [Google Scholar]
  39. Yanovski JA. Trends in underweight and obesity — scale of the problem. Nat Rev Endocrinol 2018; 14:5–6 [View Article]
     [Google Scholar]
  40. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101:15718–15723 [View Article] [PubMed]
     [Google Scholar]
  41. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104:979–984 [View Article] [PubMed]
     [Google Scholar]
  42. Balakrishnan B, Selvaraju V, Chen J, Ayine P, Yang L et al. Ethnic variability associating gut and oral microbiome with obesity in children. Gut Microbes 2021; 13:1–15 [View Article] [PubMed]
     [Google Scholar]
  43. de Andrade PAM, Giovani PA, Araujo DS, de Souza AJ, Pedroni-Pereira A et al. Shifts in the bacterial community of saliva give insights on the relationship between obesity and oral microbiota in adolescents. Arch Microbiol 2020; 202:1085–1095 [View Article] [PubMed]
     [Google Scholar]
  44. Mameli C, Cattaneo C, Panelli S, Comandatore F, Sangiorgio A et al. Taste perception and oral microbiota are associated with obesity in children and adolescents. PLoS One 2019; 14:e0221656 [View Article] [PubMed]
     [Google Scholar]
  45. Stefura T, Zapała B, Gosiewski T, Skomarovska O, Dudek A et al. Differences in compositions of oral and fecal microbiota between patients with obesity and controls. Medicina 2021; 57:678 [View Article] [PubMed]
     [Google Scholar]
  46. Könönen E, Gursoy UK. Oral Prevotella species and their connection to events of clinical relevance in gastrointestinal and respiratory tracts. Front Microbiol 2021; 12:798763 [View Article] [PubMed]
     [Google Scholar]
  47. Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology 2017; 151:363–374 [View Article] [PubMed]
     [Google Scholar]
  48. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 2016; 535:376–381 [View Article] [PubMed]
     [Google Scholar]
  49. Sun Y, Guan Y, Zeng D, He K, Wu G. Metagenomics-based interpretation of AHLs-mediated quorum sensing in Anammox biofilm reactors for low-strength wastewater treatment. Chem Eng J 2018; 344:42–52 [View Article]
     [Google Scholar]
  50. Nørskov-Lauritsen N. Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans. Clin Microbiol Rev 2014; 27:214–240 [View Article] [PubMed]
     [Google Scholar]
  51. Ye Z, Lu Y, Wu T. The impact of ATP-binding cassette transporters on metabolic diseases. Nutr Metab 2020; 17:61 [View Article]
     [Google Scholar]
  52. Harris MT, Hussain SS, Inouye CM, Castle AM, Castle JD. Reinterpretation of the localization of the ATP binding cassette transporter ABCG1 in insulin-secreting cells and insights regarding its trafficking and function. PLoS One 2018; 13:e0198383 [View Article] [PubMed]
     [Google Scholar]
  53. Davidson AL, Chen J. ATP-binding cassette transporters in bacteria. Annu Rev Biochem 2004; 73:241–268 [View Article] [PubMed]
     [Google Scholar]
  54. D’Angelo G, Capasso S, Sticco L, Russo D. Glycosphingolipids: synthesis and functions. FEBS J 2013; 280:6338–6353 [View Article] [PubMed]
     [Google Scholar]
  55. Iqbal J, Walsh MT, Hammad SM, Hussain MM. Sphingolipids and lipoproteins in health and metabolic disorders. Trends Endocrinol Metab 2017; 28:506–518 [View Article] [PubMed]
     [Google Scholar]
  56. van Eijk M, Aten J, Bijl N, Ottenhoff R, van Roomen CPAA et al. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. PLoS One 2009; 4:e4723 [View Article] [PubMed]
     [Google Scholar]
  57. Schlaberg R. Microbiome diagnostics. Clin Chem 2020; 66:68–76 [View Article] [PubMed]
     [Google Scholar]
  58. Liao C, Rolling T, Djukovic A, Fei T, Mishra V et al. Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes. Nat Microbiol 2024; 9:1555–1565 [View Article] [PubMed]
     [Google Scholar]
  59. Yamazaki K, Kamada N. Exploring the oral-gut linkage: interrelationship between oral and systemic diseases. Mucosal Immunol 2024; 17:147–153 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.002020
Loading
Oral microbiota signatures in obesity with or without acanthosis nigricans in a Chinese cohort
J. Med. Microbiol. 74, 002020 (2025); https://doi.org/10.1099/jmm.0.002020
/content/journal/jmm/10.1099/jmm.0.002020
/content/journal/jmm/10.1099/jmm.0.002020
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error